GIST PDGFRA GENE MUTATIONS, BLOCKS
This test detects mutations in the PDGFRA gene associated with gastrointestinal stromal tumors (GISTs). These mutations affect the growth of GISTs, and the test helps in determining the appropriate treatment, especially with targeted therapies like imatinib. It aids in prognosis and treatment planning.
GIST PDGFRA GENE MUTATIONS, BLOCKS Test in Bengaluru Overview
What is GIST PDGFRA gene mutation test?
The GIST PDGFRA gene mutation test detects mutations in the PDGFRA gene, which are associated with gastrointestinal stromal tumors (GISTs).
Why consider GIST PDGFRA gene mutation test?
- Therapy selection: PDGFRA D842V confers primary resistance to imatinib and many first‑line TKIs, prompting use of agents with demonstrated activity against D842V variants and avoiding ineffective therapy.
- Prognostic value: PDGFRA‑mutant GISTs—often gastric and epithelioid—can have different behavior; certain exon 18 variants are associated with lower metastatic potential compared with some KIT exon 9/11 mutations.
- Diagnostic clarification: In KIT‑negative or equivocal cases, PDGFRA genotyping establishes an oncogenic driver and supports definitive GIST diagnosis within a comprehensive workup.
Who should get tested for GIST PDGFRA gene mutation test?
Patients diagnosed with GIST or those with a family history of gastrointestinal cancers should undergo this test for better treatment planning.
- Newly diagnosed GIST where KIT testing is negative, inconclusive, or pending, to determine the driver mutation and inform targeted therapy decisions.
- Tumors with gastric, epithelioid morphology or low/negative KIT IHC, which are enriched for PDGFRA alterations and derive management benefit from precise genotyping.
- Patients being considered for TKI therapy or clinical trials with eligibility contingent on PDGFRA mutation status, particularly exon 18 D842V.
More Information about GIST PDGFRA gene mutation test
Gastrointestinal stromal tumors (GISTs) are rare cancers that develop in the specialized cells of the digestive tract wall, known as the interstitial cells of Cajal. Most GISTs occur in the stomach or small intestine, driven by gene mutations (primarily in the KIT gene) that cause uncontrolled cell growth.
OTHER NAMES: PDGFRA mutation analysis for GIST (FFPE blocks), GIST PDGFRA hotspot testing (exons 12, 14, 18), PDGFRA genotyping for TKI selection in GIST.
No special preparations needed
- Pdgfra Gene Mutations
- Block Identification Number
- Clinical Details
Test code
RD1443
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Paraffin Block | Others | 1 NOS |
Specimen stability information
Paraffin Block
Collection instructions
Site Of Biopsy & Clinical Details Mandatory If Tissue Recd
Specimen rejection criteria
Test run frequency
Every Day TIME - 10:30
Turn around time
7 Working Days
Performing locations
Department
- Advanced Molecular Diagnostics R&d
CPT and Loinc codes
Package price
₹10000
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestGIST PDGFRA GENE MUTATIONS, BLOCKS
₹10000